Lyell Immunopharma (LYEL) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-3.6
-2.46
-1.31
-0.17

Details

Expected EPS
-2.6425
Actual EPS
-2.13
Surprise EPS
0.51
Surprise Percent
+19.39%

Description

Lyell Immunopharma (LYEL) has reported earnings of -2.13 per share for Q4 2025.

0 Comments

Share your thoughts